May 8 (Reuters) - EMA:
EMA: CONFIRMED SUICIDAL IDEATION AS A SIDE EFFECT OF FINASTERIDE 1 AND 5 MG TABLETS
EMA: PRAC AGREED THAT SUICIDAL IDEATION SHOULD BE INCLUDED AS A SIDE EFFECT OF FINASTERIDE TABLETS
EMA: NOT POSSIBLE TO ESTABLISH A LINK BETWEEN SUICIDAL IDEATION AND DUTASTERIDE
EMA: NO EVIDENCE LINKING SUICIDAL IDEATION TO FINASTERIDE SKIN SPRAYS
Further company coverage: OGN.N
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.